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Original Article
Trends in the magnitude of chronic
conditions in patients hospitalized with a
first acute myocardial infarction
Mayra Tisminetzky1,2,3 , Ruben Miozzo4, Joel M Gore3,5,
Jerry H Gurwitz1,2,3, Darleen Lessard3, Jorge Yarzebski3,
Edgard Granillo3, Hawa O Abu5 and Robert J Goldberg1,3
Abstract
Background: Among adults with heart disease, there is a high prevalence of concomitant chronic medical conditions.
We studied patients with a first acute myocardial infarction to describe: sample population characteristics; trends of the
most prevalent pairs of chronic conditions; and differences in hospital management according to burden of these
morbidities.
Methods and Results: Patients (n ¼ 1,564) hospitalized with an incident AMI at the 3 major medical centers in central
Massachusetts during 2005, 2011, and 2015 comprised the study population. Hospital medical records were reviewed to
identify 11 more prevalent chronic conditions. The median age of this population was 68 years and 56% were men. The
median number of previously diagnosed chronic conditions was 2. Patients hospitalized during 2015 were more likely to
be younger than those hospitalized in the earliest study cohorts. The most common pairs of chronic conditions for
those hospitalized in 2005 were: anemia-chronic kidney disease (31%), chronic kidney disease-heart failure (30%), and
stroke-atrial fibrillation (27%). Among patients hospitalized during 2011, chronic kidney disease-heart failure (29%),
hypertension-hyperlipidemia (27%), and hypertension-diabetes (27%) were the most common pairs whereas
hypertension-hyperlipidemia (43%), diabetes-heart failure (30%), and chronic kidney disease-diabetes (23%) were the
most frequent pairs recorded in 2015. There was a significant decrease in the odds of undergoing cardiac catheterization
and a percutaneous coronary intervention in those with higher chronic disease burden in the most recent as compared to
earliest study years.
Conclusions: Our findings highlight the magnitude of chronic conditions in patients with AMI and the challenges of caring
for this vulnerable population.
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Introduction
The prevalence of multiple chronic diseases in patients
hospitalized with an acute myocardial infarction (AMI) has
become increasingly common.1 Patients with multiple
chronic conditions (MCCs) are at substantial risk for dis-
ability, death, and poor quality of life, and account for a
disproportionate share of U.S. health care related expendi-
tures.2–7 The clinical management of persons hospitalized
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with an AMI and MCCs is particularly challenging, due in
part to their high risk for adverse events, as well as the need
for complex and tailored therapeutic regimens.8 Despite the
high prevalence of MCCs in patients hospitalized for an
AMI, there are relatively limited contemporary data
describing the magnitude, characteristics, and hospital
management of patients hospitalized with an incident AMI
and MCCs. Moreover, data remain lacking about trends in
the most frequent pairs of chronic conditions that compli-
cate the management of these patients from a more general-
izable community-based perspective.9–12 The objectives of
this observational study were to describe and compare the
demographic and clinical characteristics of individuals hos-
pitalized with an initial AMI in 2005, 2011, and 2015 as
part of a community-based coronary disease surveillance
study. We further examined and compared the most pre-
valent pairs of chronic conditions and the in-hospital clin-
ical management of those with a high (>3) vs. low (<2)
number of chronic conditions during the 3 years under
study.
Methods
The Worcester Heart Attack Study is an ongoing
population-based investigation that is examining long-
term trends in the clinical epidemiology of AMI among
residents of the Worcester, Massachusetts (MA), metropol-
itan area hospitalized at all medical centers in central MA
on an approximate biennial basis.13–17
Computerized medical record printouts of residents of
central MA admitted to the three major hospitals that treat
patients with acute coronary disease in the Worcester met-
ropolitan area with possible AMI (International Classifica-
tion of Disease (ICD) 9 codes 410–414, and 786.5) were
identified. Cases of possible AMI were independently vali-
dated using predefined criteria for AMI, including diag-
noses of ST segment elevation myocardial infarction
(STEMI) and non-ST segment elevation myocardial infarc-
tion (NSTEMI).18,19 The present study was restricted to
patients with an initial AMI because we were interested
in describing the clinical features and the presence of other
chronic conditions in those with a first clinical manifesta-
tion of underlying coronary atherosclerosis. Inasmuch,
patients with a history of previously diagnosed AMI (n ¼
829) based on the review of hospital medical records were
excluded from the present study. This study was approved
by the Institutional Review Board at the University of Mas-
sachusetts Medical School.
Trained nurses and physicians abstracted information on
patient’s demographic and clinical characteristics. These
characteristics included patient’s age, sex, race/ethnicity,
hospital length of stay, and previously diagnosed chronic
conditions including anemia, atrial fibrillation, asthma/
chronic pulmonary disease, chronic kidney disease, depres-
sion, diabetes, heart failure, hyperlipidemia, hypertension,
peripheral vascular disease, and stroke. These 11 chronic
conditions were selected based on their high prevalence in
our study cohort and because they occurred at a frequency
>3%.20–22 Data on the receipt of three coronary diagnostic
and interventional procedures [cardiac catheterization, per-
cutaneous coronary intervention (PCI), and coronary artery
bypass graft surgery (CABG)] during hospitalization, and
evidence-based pharmacotherapies, namely angiotensin
converting inhibitors (ACE-I)/angiotensin receptor block-
ers (ARBs), aspirin, beta blockers, and lipid lowering
agents were also obtained. The 3 study periods of 2005,
2011, and 2015 were selected for purposes of examining
decade long trends in patient’s demographic and clinical
characteristics and prevalent pairs of chronic conditions in
our study cohorts.
We compared differences in various demographic and
clinical characteristics between patients hospitalized dur-
ing our 3 study years using chi square tests for categorical
variables and the ANOVA test for continuous variables.
We calculated a tetrachoric correlation, a type of correla-
tion applicable when both observed variables are dichoto-
mous,23 to determine the most prevalent pairs of
morbidities among all the possible combinations of the
11 chronic conditions examined in the present study.
We further stratified our study population into two
groups for purposes of examining the impact of high (>3)
versus low (<2) burden of chronic conditions in the clinical
management of patients hospitalized with an AMI. We
used two conditions as a cut point because it was the med-
ian number of chronic conditions observed in our study
population. Logistic regression models (unadjusted and
adjusted for age and sex) were utilized to estimate the odds
of receiving cardiac related medications and diagnostic/
interventional procedures according to the presence of
chronic conditions during the index hospitalization for
AMI across the 3 study years.
Results
A total of 1,564 residents of central MA were hospitalized
with an independently validated first AMI at all three major
medical centers in central Massachusetts during the period
under study. The median age of this patient population was
68 years and 56% were men. The average number of pre-
viously diagnosed chronic conditions in this population
was 2.7 while the median number was 2.0. The average
and median number of chronic conditions in this patient
population did not change during the years under study.
Patients hospitalized during 2015 were more likely to be
younger and male but slightly less likely to present with a
NSTEMI than those hospitalized in 2005 (Table 1).
Patients hospitalized during the 2 most recent study
years of 2011 and 2015 were more likely to have been
previously diagnosed with chronic kidney disease, dia-
betes, and hyperlipidemia as compared with those hospita-
lized during 2005. On the other hand, those hospitalized
during the most recent study years were less likely to have
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been previously diagnosed with anemia, heart failure, and
stroke than those hospitalized during 2005 (Table 1). The
cumulative burden of chronic conditions was relatively
similar across the 3 study years, with almost one in five
individuals presenting with three chronic conditions and
1/3 of the study sample presenting with four or more
chronic conditions.
The most common pairs of chronic conditions for those
hospitalized with a first AMI in 2005 were: anemia-chronic
kidney disease, chronic kidney disease-heart failure, and
stroke-atrial fibrillation (31%, 30%, and 27% of patients,
respectively) (Figure 1). For those hospitalized during
2011, the most common pairs of chronic conditions were:
chronic kidney disease-heart failure (29%) hypertension-
hyperlipidemia (27%) and hypertension-diabetes (27%)
(Figure 2). Among those hospitalized during the most
recent study year of 2015, the most common pairs were:
hypertension-hyperlipidemia, diabetes-heart failure, and
chronic kidney disease-diabetes (43%, 30%, and 23%,
respectively (Figure 3).
Overall, the proportion of patients who received any of
the diagnostic/interventional cardiac procedures was sig-
nificantly higher during 2015 as compared with 2005 and
2011, with the exception of the receipt of a percutaneous
coronary intervention (PCI) that remained unchanged over
time (Table 2).
The proportion of patients who received lipid lowering
medication and aspirin was significantly higher during
2015 as compared with the earliest study years, whereas
there was a marked decline in the use of ACE inhibitors/
ARBs in the most recent patient cohort (Table 2).
The proportion of patients who received any of the four
cardiac related medications was similar between those who
presented with two or fewer chronic conditions as compared
to those with three or more conditions in 2005, 2011, and
2015. Unadjusted and adjusted regression analyses were per-
formed to more systematically examine trends in hospital
clinical management practices (Table 3). Results of the
unadjusted analysis showed no differences in the odds of
receiving any of the four examined cardiac related medica-
tions according to the presence of chronic conditions during
the years under study. These results essentially remained
unchanged after adjusting for age and sex.
The proportion of patients who underwent a cardiac
catheterization and a PCI was significantly lower in those
who presented with 3 or more previously diagnosed condi-
tions as compared to those who presented with 2 or fewer
conditions during the years under study (Table 4). Results
of the unadjusted analysis showed a 60% and 76%
decreased in the odds of undergoing a cardiac catheteriza-
tion in those with 3 or more conditions as compared with
those who presented with 2 or fewer conditions during
2011 and 2015, respectively. After adjusting for age and
sex, the odds of undergoing a cardiac catheterization
remained lower in those with 3 or more conditions as com-
pared to those with 2 conditions or fewer, with an approx-
imate 54% reduced likelihood in 2005 and 60% reduced
likelihood in 2015 (Table 4).
Similar trends were found in the odds of receiving a PCI.
Results of the unadjusted analysis showed a 60% decreased
odds of undergoing a PCI in those with three or more chronic
conditions as compared with those who presented with two or
fewer previously diagnosed chronic conditions. After adjust-
ing for age and sex, the odds of receiving a PCI remained
lower in those with three or more conditions as compared to
those with two conditions or fewer, with a 40% reduced like-
lihood in 2005 and 70% reduced likelihood in 2015 (Table 4).
We also examined trends in the odds of undergoing a
CABG during the index hospitalization for AMI; although
there was a slight increase in the odds of undergoing a
CABG during the most recent study years according to the
presence of MCCs, these findings were not statistically
significant (Table 4).
Due to some potential differences in the characteristics
of patients with and without do not resuscitate orders
(DNR) at the time of their hospitalization for AMI; we also
performed a sensitivity analysis including DNR as a cov-
ariate when we examined the association of receiving car-
diac related medications and diagnostic/interventional
procedures according to the presence of chronic conditions.
No differences were noted in our observed estimates of
receiving any of the cardiac related medications and
Table 1. Characteristics of patients hospitalized with an initial








Age (years) (median) 73 66 64*
Male (%) 51.7 59.2 58.7*
White race 91.9 90.8 84.2*
NSTEMI 63.9 65.5 60.7
Do not resuscitate orders 24.1 17.0 13.2**
Medical history (%)
Anemia 11.5 11.2 7.3
Atrial fibrillation 11.9 11.8 10.6




Depression 16.3 13.5 13.9
Diabetes 28.3 32.8 33.2
Heart failure 19.7 12.7 12.8**
Hyperlipidemia 52.2 67.4 66.2**
Hypertension 72.0 69.4 72.3
Peripheral vascular disease 17.6 17.7 12.3*
Stroke 9.2 6.4 5.3
Cumulative number of
comorbidities ( %)
Any 2 or fewer 51.2 50.3 50.3
Any 3 20.3 19.7 20.0
Any 4 or more 28.5 30.1 29.7
* p value <0.05. ** p value <0.001. NSTEMI: Non-ST-elevation myocardial
infarction.
Tisminetzky et al. 3





















2005 Cohort,  Frequency of pairs, %
Figure 1. Frequency of pairs of chronic conditions during 2005.





















2011 Cohort,  Frequency of pairs, %
Figure 2. Frequency of pairs of chronic conditions during 2011.
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undergoing diagnostic/interventional procedures that we
examined after adjusting for patient’s DNR status.
Discussion
In this population-based study of adults hospitalized with a
first AMI at all three major medical centers serving
residents of the Worcester metropolitan area, we found that
the most prevalent pairs of previously diagnosed chronic
conditions in 2005 were anemia/chronic kidney disease,
chronic kidney disease/heart failure, and stroke/atrial fibril-
lation. On the other hand, during the most recent study year
of 2015, the most frequent pairs of chronic conditions were
hypertension/hyperlipidemia, diabetes/heart failure, and
chronic kidney disease/diabetes. While we did not observe
any changes in the hospital prescribing of effective cardiac
medications according to burden of chronic conditions dur-
ing the years under study, we observed a significant
decrease in the odds of undergoing a cardiac catheterization
and a PCI according to the burden of chronic conditions in
the most recent years under study.
Our findings suggest that individuals hospitalized for a
first AMI during the most recent study years tended to be
younger as compared with those hospitalized in 2005. We
observed a higher prevalence of diabetes and chronic kid-
ney disease as well as a lower prevalence of anemia and
stroke in the most recent as compared with earliest study
cohort.
Our findings are similar to the results of other investi-
gations. In a study of more than 30,000 patients (mean age:
64 years) with an acute coronary syndrome in the nation-
wide AMIS Plus registry in Switzerland between 2002 and





















2015 Cohort,  Frequency of pairs, %
Figure 3. Frequency of pairs of chronic conditions during 2015.


















Lipid lowering agents 64.1 87.3 92.1**
Aspirin 94.4 94.8 96.0
ACE/ARBS 70.2 66.3 55.6**
Beta-blocker agent 94.6 91.7 90.8*
* p value <0.05. ** p value <0.001.
ACE/ARBS: angiotensin converting enzyme inhibitors/Angiotensin II
receptor blockers.












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2012, two of the most prevalent conditions in this popula-
tion were diabetes (15%) and chronic kidney disease
(7%).24 In a study of more than 5,000 patients hospitalized
with AMI in Spain between 2003 and 2009, the most pre-
valent chronic conditions were hypertension (49%), dia-
betes (38%), heart failure (25%), and kidney disease
(11%).25
These collective findings suggest that patients hospita-
lized with a first AMI present with a high prevalence of
diabetes and chronic kidney disease, which clinicians
involved in the diagnosis, clinical management, and edu-
cation of these individuals need to be aware of. Health care
providers need to work together with patients and their
caregivers to ensure adherence to their complex treatment
regimens and in the implementation of lifestyle interven-
tions to help this vulnerable population to manage their
diverse chronic conditions.
Our findings suggest that the most prevalent pairs of
chronic conditions during the most recent year under study
were hypertension/hyperlipidemia, diabetes/heart failure,
and chronic kidney disease/diabetes.
Few studies have examined the frequency of particular
pairs of chronic conditions in patients hospitalized with an
AMI. One of the few studies that described the frequency of
pairs of chronic conditions in these patients was a study in
Melbourne, Australia that included approximately 1,500
older adults (mean age: 79 years) hospitalized with a
non-ST-elevation AMI.26 Diabetes and renal disease
(13%) co-existed frequently in this patient population.
Somewhat different pairs of frequently occurring chronic
conditions were described in the Transitions, Risks, and
Actions in Coronary Events Center for Outcomes Research
and Education study, which longitudinally followed 2,174
adults hospitalized with an acute coronary syndrome at five
medical centers in MA and GA.22 The most frequently
diagnosed pairs of chronic conditions found in this cohort
at the time of baseline study enrollment were hyperlipide-
mia and hypertension, diabetes and hypertension, and dia-
betes and hyperlipidemia (60%, 28%, and 26%,
respectively).
Differences in the most common chronic conditions in
patients hospitalized with acute coronary disease are likely
explained by differences in the socio-demographic and
clinical characteristics of the respective study populations,
periods under study, lack of consensus in terms of the
chronic conditions included in these investigations, and
working definitions used to classify the comorbidities
under study. Monitoring trends in the frequency of various
chronic conditions among patients hospitalized with an
AMI is of continued importance to guide health care pro-
viders in clinical decision-making and in the management
of these complex patients.
In contrast to our proposed hypotheses, we failed to
observe differences in the prescribing of effective car-
diac medications according to the frequency of chronic
conditions during the years under study; however, we
found a significant decrease in the odds of undergoing
a cardiac catheterization and a PCI according to the
magnitude of chronic conditions during the decade long
period under study. We also observed a slight increase
in the odds of undergoing a CABG during the most
recent study years according to the number of chronic
conditions present, consistent with the findings from
other investigations.7,24,27,28
In a study of nearly 3,000 patients with AMI treated at
53 hospitals in Ontario, Canada between 1999 and 2003,
the number of pre-existing conditions was inversely asso-
ciated with the receipt of coronary reperfusion therapy.27
These investigators suggested that a possible explanation
for this treatment-risk paradox may have been due to phy-
sicians being generally averse to providing more aggressive
treatments to patients with MCCs because they perceive
these interventions as either risky or futile due to the com-
plexity and overall fragility of the patient’s health status.27
Data from the AMIS Plus registry found that patients with
MCCs were less likely to have received coronary reperfu-
sion therapy (47%) as compared to patients without these
underlying conditions (79%).24 Other possible explanations
for the observed lower likelihood of undergoing a cardiac
catheterization and a PCI in the present study among those
with higher burden of MCCs could be attributed to the
clinical characteristics of the patient populations studied,
such as a higher prevalence of diabetes and chronic kidney
disease.29
Our findings, in combination with prior study findings,
emphasize the importance of developing comprehensive
management guidelines specifically tailored to hospitalized
AMI patients with MCCs given the increasing prevalence
of this vulnerable population and their high risk of devel-
oping adverse outcomes. Moreover, future studies should
investigate the use of more aggressive early detection mea-
sures and/or treatment focus on particular prevalent pairs of
comorbidities that might place individuals at higher risk of
death or that might worsen prognoses.
Importantly, efforts to reduce these risks are particularly
challenging as most clinical practice guidelines do not take
comorbidity pairs into account in providing treatment rec-
ommendations.30 Caution is required in applying estab-
lished clinical practice guidelines to the care of
individuals with AMI and other chronic conditions since
this could result in undesirable effects and less than optimal
outcomes including adverse interactions between drugs and
various conditions.8 The paucity of relevant clinical evi-
dence worsens an all-too common quandary faced by
health care providers in making clinical decisions regarding
the care of individuals with AMI. Physicians struggle with
the dilemma of using treatments that may not be beneficial
and that could cause harm to these complex patients versus
denying effective treatments to patients at high risk for
dying who could benefit from more aggressive
management.8,30
Tisminetzky et al. 7
The strengths of the present study include its
community-based design and its large sample of patients
hospitalized with an independently validated first AMI
over a decade long period. Several limitations, however,
need to be acknowledged in the interpretation of the present
findings. Since our study population only included patients
who had been hospitalized in central MA, extrapolation of
our findings to those who reside in other geographic areas
should be considered with regard to the generalizability of
our population and healthcare environment. Second, since
the majority of study patients were white, the generaliz-
ability of our findings to other race/ethnic groups may be
limited. We did not have available community-based data
on the primary and secondary risk factors for AMI in
younger individuals in central MA population and how the
conventional and novel predisposing factors may have
changed over time. Lastly, there is always the potential for
unmeasured confounding in an observational study since
we did not have information available on several patient-
associated characteristics, such as income, education,
severity of chronic disease, or time since diagnosis of the
chronic conditions under study
The findings of the present investigation highlight the
magnitude of a variety of chronic conditions in patients
hospitalized with an AMI. Since some chronic condi-
tions, such as diabetes and chronic kidney disease, were
more frequently diagnosed in patients hospitalized dur-
ing the most recent study years, health care providers
should be increasingly aware of the most prevalent pairs
of chronic conditions in order to improve the in-hospital
management of the most vulnerable groups. Our find-
ings highlight the importance of developing future
guidelines and clinical trials to focus on the manage-
ment, in-hospital, and long-term outcomes of individuals
with MCCs.
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